Delivery Order SPE2D021DA002-SPE2D326F1706
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a $3,833.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, was made without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,279.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector sets. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in...
- The Defense Logistics Agency, through its Medical Supply Chain function, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Epinephrine 0.3 mg auto-injector two-packs. The contract, valued at $1,742.50 with an ultimate completion date of August 25, 2025, was awarded on August 20, 2025, on a firm fixed-price basis with no set-aside designation. The vendor will perform deliveries from its Park Ridge, Illinois facility. This...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price delivery order, valued at $2,590.25, was awarded on November 26, 2025, with completion scheduled for November 28, 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA), acting under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 2, 2025, has a ceiling value of $1,916.75 and is scheduled for completion by October 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance by the vendor from its location in Park Ridge, Illinois. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,202.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector (2 units). The award, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. Performance will be executed in Conshohocken, Pennsylvania....
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector kits (two-pack) with a contract ceiling value of $1,045.50. The award, issued on June 27, 2025, with an ultimate completion date of July 2, 2025, was made without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge,...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for Epinephrine 0.3 mg auto-injector units (2-pack configuration) with a ceiling value of $1,394.00. The award, issued on July 23, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. This delivery order was issued without set-aside designation and is being fulfilled at the contractor's facility in...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of epinephrine 0.3 mg auto-injector 2-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with an ultimate completion date of August 28, 2025. The award was issued without a set-aside designation, allowing the vendor to...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. The award, issued on September 5, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Park Ridge location. The...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F1706Delivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,045.50. Issued on December 1, 2025, with an ultimate completion date of December 2, 2025, this firm fixed-price delivery order represents a routine procurement under the company's existing pharmaceutical supply contract. The award utilized no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with comprehensive pharmaceutical and medical supply sourcing through multiple regional prime vendor contractors. Through this master contract vehicle, DMS Pharmaceutical Group serves as a critical supplier of branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and emergency medications including epinephrine auto-injectors to support military healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/30/25 |